Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA)
暂无分享,去创建一个
D. Holtzman | A. Shih | H. Snyder | D. Werring | M. D. de Leon | R. Carare | E. Hamel | N. Agarwal | S. Greenberg | V. Leinonen | B. Bacskai | R. Kalaria | D. Wilcock | P. Eide | G. Bu | D. Bulters | R. Weller | J. McLaurin | B. Zlokovic | A. Hainsworth | S. Counts | M. Koronyo-Hamaoui | C. Kipps | T. Malm | K. Kanninen | Mark R. Wilson | A. Jefferson | D. Boche | J. Nicoll | S. Miners | A. Verma | M. Ihara | Susanne J. van Veluw | S. Fossati | F. Piazza | H. Scholtzova | C. Hawkes | G. Paul | Roxana Aldea | S. Saito | F. Thormodsson | I. Bechman | Alt Clemens | Steven M. Rich | Peter J. Snyder | Nivedita Agarwal
[1] L. Schneider. Developing appropriate methodologies for effective clinical trial engagement in vascular cognitive impairment and dementia (VCID) , 2020 .
[2] Andreas A. Linninger,et al. In Vivo Intrathecal Tracer Dispersion in Cynomolgus Monkey Validates Wide Biodistribution Along Neuraxis , 2020, IEEE Transactions on Biomedical Engineering.
[3] T. Wisniewski,et al. Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis) , 2020, Frontiers in Aging Neuroscience.
[4] A. Tannenbaum,et al. Perivascular spaces in the brain: anatomy, physiology and pathology , 2020, Nature Reviews Neurology.
[5] A. Ljubimov,et al. Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina , 2020, Acta Neuropathologica.
[6] R. Carare,et al. Vasomotion Drives Periarterial Drainage of Aβ from the Brain , 2020, Neuron.
[7] David A Hartmann,et al. Mild pericyte deficiency is associated with aberrant brain microvascular flow in aged PDGFRβ+/− mice , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] P. Eide,et al. Cerebrospinal fluid tracer efflux to parasagittal dura in humans , 2020, Nature Communications.
[9] P. Mozley,et al. Intrathecal 99mTc‐DTPA imaging of molecular passage from lumbar cerebrospinal fluid to brain and periphery in humans , 2020, Alzheimer's & dementia.
[10] R. Sperling,et al. Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways , 2019, Nature Reviews Neurology.
[11] M. Frosch,et al. Vasomotion as a Driving Force for Paravascular Clearance in the Awake Mouse Brain , 2019, Neuron.
[12] Mohammed Q. Qutaish,et al. Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging. , 2019, JCI insight.
[13] C. Supuran,et al. A New Kid on the Block? Carbonic Anhydrases as Possible New Targets in Alzheimer’s Disease , 2019, International journal of molecular sciences.
[14] A. Dorrance,et al. Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease. , 2019, Journal of Alzheimer's disease : JAD.
[15] C. Holmes,et al. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease , 2019, Brain : a journal of neurology.
[16] L. Beckett,et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities , 2019, Alzheimer's & dementia.
[17] C. Berka,et al. Transcranial Impedance Changes during Sleep: A Rheoencephalography Study , 2019, IEEE Journal of Translational Engineering in Health and Medicine.
[18] R. Carare,et al. Cerebrovascular Smooth Muscle Cells as the Drivers of Intramural Periarterial Drainage of the Brain , 2019, Front. Aging Neurosci..
[19] Eric E. Smith,et al. Vascular dysfunction—The disregarded partner of Alzheimer's disease , 2019, Alzheimer's & Dementia.
[20] Scott T. Acton,et al. Functional aspects of meningeal lymphatics in aging and Alzheimer’s disease , 2018, Nature.
[21] M. D. de Leon,et al. Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity , 2018, Aging cell.
[22] Roxana O. Carare,et al. Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways , 2018, Acta Neuropathologica.
[23] G. Bu,et al. ApoE4 Accelerates Early Seeding of Amyloid Pathology , 2017, Neuron.
[24] D. Werring,et al. Animal models of cerebral amyloid angiopathy. , 2017, Clinical science.
[25] R. Carare,et al. LOSS OF CLUSTERIN SHIFTS AMYLOID DEPOSITION TO THE CEREBROVASCULATURE VIA DISRUPTION OF PERIVASCULAR DRAINAGE PATHWAYS , 2017, Alzheimer's & Dementia.
[26] E. Ólafsson,et al. Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy , 2017, Laboratory Investigation.
[27] H. Rusinek,et al. Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET , 2017, The Journal of Nuclear Medicine.
[28] David A Hartmann,et al. Organizational hierarchy and structural diversity of microvascular pericytes in adult mouse cortex , 2017, bioRxiv.
[29] A. Zoubeidi,et al. Clusterin as a therapeutic target , 2017, Expert opinion on therapeutic targets.
[30] D. Wilcock,et al. Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID). , 2016, Biochimica et biophysica acta.
[31] D. Holtzman,et al. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer’s disease , 2016, Science Translational Medicine.
[32] D. Wilcock,et al. Animal Models of Vascular Cognitive Impairment and Dementia (VCID) , 2016, Cellular and Molecular Neurobiology.
[33] R. Carare,et al. Vascular basement membranes as pathways for the passage of fluid into and out of the brain , 2016, Acta Neuropathologica.
[34] J. Ghiso,et al. The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain , 2016, Neurobiology of Disease.
[35] Per Kristian Eide,et al. MRI with intrathecal MRI gadolinium contrast medium administration: a possible method to assess glymphatic function in human brain , 2015, Acta radiologica open.
[36] M. Ihara,et al. New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy , 2014, Front. Aging Neurosci..
[37] R. Carare,et al. Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid , 2014, Annals of clinical and translational neurology.
[38] E. Ólafsson,et al. Deposition of collagen IV and aggrecan in leptomeningeal arteries of hereditary brain haemorrhage with amyloidosis , 2013, Brain Research.
[39] R O Weller,et al. Review: Cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy , 2013, Neuropathology and applied neurobiology.
[40] V. Perry,et al. Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer’s disease , 2013, Acta neuropathologica communications.
[41] Brian J. Bacskai,et al. Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer’s disease mouse models , 2013, Acta Neuropathologica.
[42] R. Carare,et al. Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid‐β from the mouse brain , 2013, Aging cell.
[43] Antonio Colombo,et al. Anti–amyloid β autoantibodies in cerebral amyloid angiopathy–related inflammation: Implications for amyloid‐modifying therapies , 2013, Annals of neurology.
[44] R. Carare,et al. Disruption of Arterial Perivascular Drainage of Amyloid-β from the Brains of Mice Expressing the Human APOE ε4 Allele , 2012, PloS one.
[45] Nick C Fox,et al. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis , 2012, The Lancet Neurology.
[46] Keith L. Black,et al. Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment , 2012, Neurodegenerative Diseases.
[47] R. Kalaria,et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts , 2011, Acta Neuropathologica.
[48] Clifford R. Jack,et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup , 2011, Alzheimer's & Dementia.
[49] Daniel L. Farkas,et al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model , 2011, NeuroImage.
[50] G. Halliday,et al. Oligomeric Aβ40 species accumulate in the toxic plaques in Alzheimer's disease , 2009, Alzheimer's & Dementia.
[51] J. McLaurin,et al. Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebral amyloid angiopathy , 2009, Proceedings of the National Academy of Sciences.
[52] Katie Hamm,et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. , 2008, The Journal of clinical investigation.
[53] R O Weller,et al. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. , 2008, Brain : a journal of neurology.
[54] T. Révész,et al. Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene‐related dementias: a morphological study , 2006, Neuropathology and applied neurobiology.
[55] D. Wilcock,et al. Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration , 2004, Neurobiology of Disease.
[56] U. Dirnagl,et al. Immune surveillance of mouse brain perivascular spaces by blood‐borne macrophages , 2001, The European journal of neuroscience.
[57] E. Matsubara,et al. Isoform‐Specific Effects of Apolipoproteins E2, E3, and E4 on Cerebral Capillary Sequestration and Blood‐Brain Barrier Transport of Circulating Alzheimer's Amyloid β , 1997, Journal of neurochemistry.
[58] R O Weller,et al. Pathways of Fluid Drainage from the Brain ‐ Morphological Aspects and Immunological Significance in Rat and Man , 1992, Brain pathology.
[59] R O Weller,et al. Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum. , 1990, Journal of anatomy.
[60] H. Soininen,et al. Predicting Development of Alzheimer's Disease in Patients with Shunted Idiopathic Normal Pressure Hydrocephalus. , 2019, Journal of Alzheimer's disease : JAD.
[61] B. Winblad,et al. Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers? , 2016, Journal of Alzheimer's disease : JAD.
[62] D. Wilcock,et al. β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice , 2014, Alzheimer's Research & Therapy.
[63] E. Zhang,et al. Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain , 2004, Acta Neuropathologica.
[64] D. Wilcock,et al. Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration. , 2004, Neurobiology of disease.